7 Eden Park Drive
Level 5
Macquarie Park, NSW 2113
Australia
61 2 8935 9629
https://www.oncosil.com.au
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Nigel Lange | CEO, MD & Director | 388,26k | N/A | N/A |
Mr. Christian Dal Cin | CFO & Company Secretary | N/A | N/A | N/A |
Dr. Ralph Peters | Chief Medical Officer | N/A | N/A | N/A |
Mr. David Turner | Head of Medical Affairs | N/A | N/A | N/A |
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
OncoSil Medical Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.